1. Design and tests of prospective property predictions for novel antimalarial 2-aminopropylaminoquinolones
- Author
-
Robert D. Clark, Francisco-Javier Gamo, Walter S. Woltosz, Santiago Ferrer, Jacques Prudhomme, Denise N. Morris, Gary Chinigo, Michael S. Lawless, Karine G. Le Roch, Maria Jose Lafuente, and Robert Gadwood
- Subjects
PBPK ,Oxidoreductases Acting on CH-CH Group Donors ,Quantitative structure–activity relationship ,Phenotypic screening ,In silico ,Plasmodium falciparum ,030231 tropical medicine ,Dihydroorotate Dehydrogenase ,Quantitative Structure-Activity Relationship ,Antimalarial ,Quinolones ,Article ,Drug design ,Antimalarials ,Inhibitory Concentration 50 ,03 medical and health sciences ,0302 clinical medicine ,Drug Discovery ,Humans ,Enzyme Inhibitors ,Malaria, Falciparum ,Physical and Theoretical Chemistry ,030304 developmental biology ,ADME ,0303 health sciences ,Molecular Structure ,biology ,QSAR ,Chemistry ,biology.organism_classification ,Computer Science Applications ,Molecular Docking Simulation ,Drug development ,Biochemistry ,Pyrimidine metabolism ,Dihydroorotate dehydrogenase - Abstract
There is a pressing need to improve the efficiency of drug development, and nowhere is that need more clear than in the case of neglected diseases like malaria. The peculiarities of pyrimidine metabolism in Plasmodium species make inhibition of dihydroorotate dehydrogenase (DHODH) an attractive target for antimalarial drug design. By applying a pair of complementary quantitative structure–activity relationships derived for inhibition of a truncated, soluble form of the enzyme from Plasmodium falciparum (s-PfDHODH) to data from a large-scale phenotypic screen against cultured parasites, we were able to identify a class of antimalarial leads that inhibit the enzyme and abolish parasite growth in blood culture. Novel analogs extending that class were designed and synthesized with a goal of improving potency as well as the general pharmacokinetic and toxicological profiles. Their synthesis also represented an opportunity to prospectively validate our in silico property predictions. The seven analogs synthesized exhibited physicochemical properties in good agreement with prediction, and five of them were more active against P. falciparum growing in blood culture than any of the compounds in the published lead series. The particular analogs prepared did not inhibit s-PfDHODH in vitro, but advanced biological assays indicated that other examples from the class did inhibit intact PfDHODH bound to the mitochondrial membrane. The new analogs, however, killed the parasites by acting through some other, unidentified mechanism 24–48 h before PfDHODH inhibition would be expected to do so.
- Published
- 2020
- Full Text
- View/download PDF